MSLN and ovarian carcinoma: For example, Chang et al. developed a tumor cell vaccine that overexpresses mesothelin (a new tumor antigen for ovarian cancer), which, in combination with IL-12, significantly increased the proportion of mesothelin-specific T cells and prolonged mouse survival [235].